Stocks · Health care · Pharmaceutical Preparations

Enliven Therapeutics, Inc.

ELVN Clue Score23
United States Fiscal year ends December CIK 0001672619 Results filed 5 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Lori Anne Kunkel
30 Oct 2026
Director
Exercised, kept
7,300
$18.30
$133.59K
Lori Anne Kunkel
30 Oct 2026
Director
Exercised, kept
3,741
$1.12
$4.19K
Helen Louise Collins
19 Oct 2026
Chief Medical Officer
Sold after exercise
5,000
$38.47
$192.34K
Benjamin Hohl
19 Oct 2026
Chief Financial Officer
Sold after exercise
6,018
$38.48
$231.55K

What was left out

Form 4 filings counted 4
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 22,059
History held since 16 Mar 2020